Paul Hastings represented Seelos Therapeutics, Inc. in the offering, and Sichenzia Ross Ference Carmel represented Titan Partners Group.Seelos Theraputics Inc. (NASDAQ: SEEL) announced a $5.55 million public offering…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
